Delusional parasitosis: a new pathway for diagnosis and treatment
Identifieur interne : 001E39 ( Main/Exploration ); précédent : 001E38; suivant : 001E40Delusional parasitosis: a new pathway for diagnosis and treatment
Auteurs : P. Lepping [Allemagne] ; R. W. Freudenmann [Allemagne]Source :
- Clinical and Experimental Dermatology [ 0307-6938 ] ; 2008-03.
English descriptors
- Teeft :
- Antipsychotic, Antipsychotic medication, Atypical antipsychotics, Author reply, Blackwell publishing, Case reports, Clinical excellence, Delusion, Delusional, Delusional belief, Delusional disorder, Delusional intensity, Delusional parasitosis, Depot antipsychotics, Dermatologist, Dermatology, Dermatology clinics, Experimental dermatology, Freudenmann, Journal compilation, Lepping, Liaison psychiatry team, Matchbox sign, Modern antipsychotic, National institute, Parasite, Parasitosis, Particular challenges, Pathway, Prog neurol psychiatry, Psychiatric referral, Psychological medicine, Risperidone, Schizophrenia, Skin lesions, Treatment options, Uncommon disorder, Wales section.
Abstract
Delusional parasitosis is an uncommon disorder that presents particular challenges to the dermatologist. Patients often resist psychiatric referral. Evidence of efficacy of treatment options is generally weak, but some studies exist. By identifying whether the disorder is primary or secondary to another illness, by attempting to involve the liaison psychiatry team if possible and by treating the patient with a modern antipsychotic, remission is achievable. A pathway for diagnostics and therapy is presented. Treatments of choice are ‘atypical’ or second‐generation antipsychotics such as amisulpride, risperidone or olanzapine in age‐appropriate doses. Pimozide is no longer the treatment of choice, owing to a higher risk of adverse drug reactions and lower concordance. In some cases, depot antipsychotics can be considered. For diagnostics and treatment, close collaboration of dermatologists and psychiatrists is recommended.
Url:
DOI: 10.1111/j.1365-2230.2007.02635.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001177
- to stream Istex, to step Curation: 001124
- to stream Istex, to step Checkpoint: 000B74
- to stream Main, to step Merge: 001E41
- to stream Main, to step Curation: 001E39
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Delusional parasitosis: a new pathway for diagnosis and treatment</title><author><name sortKey="Lepping, P" sort="Lepping, P" uniqKey="Lepping P" first="P." last="Lepping">P. Lepping</name></author><author><name sortKey="Freudenmann, R W" sort="Freudenmann, R W" uniqKey="Freudenmann R" first="R. W." last="Freudenmann">R. W. Freudenmann</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5C522ED710CAC18D0A3143B7969B5A2A6DDE88AD</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1111/j.1365-2230.2007.02635.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-8RFVLB44-C/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001177</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001177</idno><idno type="wicri:Area/Istex/Curation">001124</idno><idno type="wicri:Area/Istex/Checkpoint">000B74</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B74</idno><idno type="wicri:doubleKey">0307-6938:2008:Lepping P:delusional:parasitosis:a</idno><idno type="wicri:Area/Main/Merge">001E41</idno><idno type="wicri:Area/Main/Curation">001E39</idno><idno type="wicri:Area/Main/Exploration">001E39</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Delusional parasitosis: a new pathway for diagnosis and treatment</title><author><name sortKey="Lepping, P" sort="Lepping, P" uniqKey="Lepping P" first="P." last="Lepping">P. Lepping</name><affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country><wicri:regionArea>North Wales Section of Psychological Medicine, Wrexham Academic Unit, Wrexham, UK; and Department of Psychiatry and Psychotherapy, University of Ulm, Ulm</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Ulm</settlement></placeName><orgName type="university">Université d'Ulm</orgName></affiliation></author><author><name sortKey="Freudenmann, R W" sort="Freudenmann, R W" uniqKey="Freudenmann R" first="R. W." last="Freudenmann">R. W. Freudenmann</name><affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country><wicri:regionArea>North Wales Section of Psychological Medicine, Wrexham Academic Unit, Wrexham, UK; and Department of Psychiatry and Psychotherapy, University of Ulm, Ulm</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Ulm</settlement></placeName><orgName type="university">Université d'Ulm</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Clinical and Experimental Dermatology</title><title level="j" type="alt">CLINICAL EXPERIMENTAL DERMATOLOGY</title><idno type="ISSN">0307-6938</idno><idno type="eISSN">1365-2230</idno><imprint><biblScope unit="vol">33</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="113">113</biblScope><biblScope unit="page" to="117">117</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2008-03">2008-03</date></imprint><idno type="ISSN">0307-6938</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0307-6938</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Antipsychotic</term><term>Antipsychotic medication</term><term>Atypical antipsychotics</term><term>Author reply</term><term>Blackwell publishing</term><term>Case reports</term><term>Clinical excellence</term><term>Delusion</term><term>Delusional</term><term>Delusional belief</term><term>Delusional disorder</term><term>Delusional intensity</term><term>Delusional parasitosis</term><term>Depot antipsychotics</term><term>Dermatologist</term><term>Dermatology</term><term>Dermatology clinics</term><term>Experimental dermatology</term><term>Freudenmann</term><term>Journal compilation</term><term>Lepping</term><term>Liaison psychiatry team</term><term>Matchbox sign</term><term>Modern antipsychotic</term><term>National institute</term><term>Parasite</term><term>Parasitosis</term><term>Particular challenges</term><term>Pathway</term><term>Prog neurol psychiatry</term><term>Psychiatric referral</term><term>Psychological medicine</term><term>Risperidone</term><term>Schizophrenia</term><term>Skin lesions</term><term>Treatment options</term><term>Uncommon disorder</term><term>Wales section</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Delusional parasitosis is an uncommon disorder that presents particular challenges to the dermatologist. Patients often resist psychiatric referral. Evidence of efficacy of treatment options is generally weak, but some studies exist. By identifying whether the disorder is primary or secondary to another illness, by attempting to involve the liaison psychiatry team if possible and by treating the patient with a modern antipsychotic, remission is achievable. A pathway for diagnostics and therapy is presented. Treatments of choice are ‘atypical’ or second‐generation antipsychotics such as amisulpride, risperidone or olanzapine in age‐appropriate doses. Pimozide is no longer the treatment of choice, owing to a higher risk of adverse drug reactions and lower concordance. In some cases, depot antipsychotics can be considered. For diagnostics and treatment, close collaboration of dermatologists and psychiatrists is recommended.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country><region><li>Bade-Wurtemberg</li><li>District de Tübingen</li></region><settlement><li>Ulm</li></settlement><orgName><li>Université d'Ulm</li></orgName></list><tree><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Lepping, P" sort="Lepping, P" uniqKey="Lepping P" first="P." last="Lepping">P. Lepping</name></region><name sortKey="Freudenmann, R W" sort="Freudenmann, R W" uniqKey="Freudenmann R" first="R. W." last="Freudenmann">R. W. Freudenmann</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E39 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E39 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5C522ED710CAC18D0A3143B7969B5A2A6DDE88AD
|texte= Delusional parasitosis: a new pathway for diagnosis and treatment
}}
| This area was generated with Dilib version V0.6.33. |  |